The Economics of Malaria Vaccine Development

Plebanski, M and Flanagan, K 2017, 'The Economics of Malaria Vaccine Development', Trends in Parasitology, vol. 33, no. 3, pp. 154-156.


Document type: Journal Article
Collection: Journal Articles

Title The Economics of Malaria Vaccine Development
Author(s) Plebanski, M
Flanagan, K
Year 2017
Journal name Trends in Parasitology
Volume number 33
Issue number 3
Start page 154
End page 156
Total pages 3
Publisher Elsevier Ltd. * Trends Journals
Abstract Vaccines that do not take a comprehensive endpoint view of the pathogen population they want to tackle early in their developmental process, may find it financially prohibitive to redesign them once they have progressed down a costly regulatory and human trial pathway. Specifically, the lead malaria vaccine candidate RTS,S has limited ability to tackle parasite polymorphism and may induce sex-specific nonspecific effects (NSEs).
Subject Immunology not elsewhere classified
DOI - identifier 10.1016/j.pt.2017.01.006
Copyright notice © 2017 Elsevier Ltd.
ISSN 1471-4922
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 1 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 0 times in Scopus Article
Altmetric details:
Access Statistics: 11 Abstract Views  -  Detailed Statistics
Created: Thu, 06 Dec 2018, 10:39:00 EST by Catalyst Administrator
© 2014 RMIT Research Repository • Powered by Fez SoftwareContact us